FDA Inspection 667676 — Daniel Saltzstein, MD
The FDA completed an inspection of Daniel Saltzstein, MD on Jun 8, 2010 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 8, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Antonio, TX (United States)
Additional Details
Clinical Investigator (CI)